Abbott

Showing 15 posts of 102 posts found.

Abbvie image

AbbVie reconsiders Shire deal over tax laws

October 15, 2014
Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax

AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …

Google image

Google partners with AbbVie on ageing

September 4, 2014
Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google

Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …

Shire image

AbbVie agrees to buy Shire for £32bn

July 18, 2014
Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

Mylan image

Mylan buys Abbott generics

July 15, 2014
Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan

Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …

abbvie image

AbbVie a step closer to Shire takeover

July 14, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

Shire image

AbbVie makes fourth Shire offer

July 9, 2014
Sales and Marketing AbbVie, Abbott, Shire, buyout, merger

The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …

Shire image

AbbVie spells out Shire benefits

June 26, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger

AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …

AbbVie logo

AbbVie moves in on Shire with $46 billion bid

June 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

Abbvie image

AbbVie highlights treatment adherence

June 12, 2014
Sales and Marketing ALIGN, AbbVie, Abbott, Crohn’s disease, TNF, ankylosing spondylitis, psoriasis, psoriatic arthritis, rheumatoid arthritis, treatment, ulcerative colitis

Patients with inflammatory diseases tend to be better at following their treatment regimes with TNF inhibitors rather than other medicines, …

Abbott logo

Abbott makes Latin America move

May 20, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging

Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …

Humira image

Humira drives AbbVie again

April 28, 2014
Sales and Marketing AbbVie, Abbott, Humira, RA

Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …

Abbvie image

AbbVie drops EMA legal case after compromise

April 4, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

Baxter to split in two next year

March 28, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro

Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …

Abbvie image

AbbVie expands into Singapore

February 10, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology

AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …

The Gateway to Local Adoption Series

Latest content